Characterization of the component, which controls the transformation between the kinetic forms of the b cytochromes.
1. In the presence of KCN and a saturating concentration of antimycin the reduction of the b-type cytochromes in submitochondrial particles is biphasic. This phenomenon was explained by suggesting the existence of two kinetic forms of cytochrome b:bA-the active form which was reduced in the rapid phase, and bS-the sluggish form which was reduced in the slow phase. The ratio between these forms and the transformation from one to other was controlled by the redox state of an unknown component, names "y", located between cytochromes b and c1. Pre-treatment with ascorbate plus N,N,N1,N1-tetramethyl-p-phenylenediamine transforms all the b-type cytochromes to their sluggish form, and the reduction by succinate follows slow monophasic kinetics. The name "dynamic control mechanism" was given to this mechanism [Eisenbach, M. & Gutman, M. (1975) Eur. J. Biochem. 52, 107-116] 2.  Increasing concentrations of antimycin (0-2 nmol/mg) in the presence of KCN increased the fraction of the rapid phase of the reduction but did not affect the calculated absolute rates of the reduction. It is concluded that antimycin delays the reduction of "y" and thus permits the observation of the biphasic phenomen, but that it is not essential for the operation of this dynamic control mechanism.
D000818:Animals; D000968:Antimycin A / Q000494:pharmacology; D002417:Cattle; D003486:Cyanides / Q000494:pharmacology; D003580:Cytochromes / Q000378:metabolism*; D005292:Ferricyanides / Q000494:pharmacology; D006912:Hydroxyquinolines / Q000494:pharmacology; D007700:Kinetics; D008931:Mitochondria, Muscle / Q000201:enzymology; D009206:Myocardium; D010084:Oxidation-Reduction; D013385:Succinate Dehydrogenase / Q000378:metabolism
D003486:Cyanides; D003580:Cytochromes; D005292:Ferricyanides; D006912:Hydroxyquinolines; D000968:Antimycin A; D013385:Succinate Dehydrogenase